-
Subject Areas on Research
-
A 102-center prospective study of seizure in association with bupropion.
-
A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV.
-
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
-
A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
-
A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder.
-
A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder.
-
Adapting smoking cessation treatment according to initial response to precessation nicotine patch.
-
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
-
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
-
Appetite and weight in children treated for ADHD.
-
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
-
Bioequivalence and Therapeutic Equivalence of Generic and Brand Bupropion in Adults With Major Depression: A Randomized Clinical Trial.
-
Brief Behavioral Therapy and Bupropion for Sleep and Fatigue in Young Adults With Crohn's Disease: An Exploratory Open Trial Study.
-
Bupropion SR in the naturalistic treatment of elderly patients with major depression.
-
Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.
-
Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.
-
Bupropion and Naltrexone in Methamphetamine Use Disorder.
-
Bupropion and guanfacine.
-
Bupropion dosing recommendations.
-
Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
-
Bupropion in chronic low back pain.
-
Bupropion in the treatment of outpatients with asthma and major depressive disorder.
-
Bupropion sustained release: a therapeutic overview.
-
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
-
Bupropion-varenicline interactions and nicotine self-administration behavior in rats.
-
Bupropion/zonisamide combination to assist smokers to switch from combustible cigarettes to electronic nicotine delivery systems (ENDS).
-
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
-
Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort.
-
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
-
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
-
Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
-
Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study.
-
Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
-
Combining antidepressant medications: a good idea?
-
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
-
Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition.
-
Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropion.
-
Cost-effectiveness analysis of the first-line therapies for nicotine dependence.
-
Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.
-
D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.
-
Depression treatment in patients with general medical conditions: results from the CO-MED trial.
-
Depression, IV: STAR*D treatment trial for depression.
-
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.
-
Development and validation of a high-throughput stereoselective LC-MS/MS assay for bupropion, hydroxybupropion, erythrohydrobupropion, and threohydrobupropion in human plasma.
-
Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine.
-
Dextromethorphan and bupropion reduces high level remifentanil self-administration in rats.
-
Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
-
Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
-
Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
-
Does Extended Pre Quit Bupropion Aid in Extinguishing Smoking Behavior?
-
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
-
Does pretreatment insomnia or anxiety predict acute response to bupropion SR?
-
Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs.
-
Effect of Extended Release Bupropion on Unilateral Ultrabrief Electroconvulsive Therapy Seizure Parameters in Major Depressive Disorder.
-
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
-
Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.
-
Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
-
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
-
Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking.
-
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.
-
Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
-
Forms of atypical depression and their response to antidepressant drugs.
-
Functional status in depressed patients: the relationship to disease severity and disease resolution.
-
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
-
Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias.
-
Medication augmentation after the failure of SSRIs for depression.
-
Misidentification of Bupropion Glucuronide Metabolites and Re-evaluation of Metabolite Pharmacokinetics.
-
Mobile contingency management as an adjunctive smoking cessation treatment for smokers with posttraumatic stress disorder.
-
Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
-
Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans.
-
New findings on nicotine addiction and treatment.
-
Omission of bupropion as a recommended treatment for PTSD.
-
Outcomes from an outpatient smoking-cessation clinic.
-
Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.
-
Patient-Informed Treatment Development of Behavioral Smoking Cessation for People With Schizophrenia.
-
Patient-reported quality of life in a randomized placebo-controlled trial of naltrexone/bupropion for obesity.
-
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
-
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
-
Public health clinical demonstration project for smoking cessation in american veterans who served since september 11, 2001.
-
Public health clinical demonstration project for smoking cessation in veterans with posttraumatic stress disorder.
-
Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders.
-
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
-
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.
-
Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir.
-
Recommendations for high-priority research on cancer-related fatigue in children and adults.
-
Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline.
-
Response to Gorelick.
-
Seizure associated with bupropion and guanfacine.
-
Seizures and bupropion: a review.
-
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
-
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.
-
Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants.
-
Stereoselective Steady-State Disposition and Bioequivalence of Brand and Generic Bupropion in Adults.
-
Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC/MS/MS.
-
Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
-
Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes.
-
Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.
-
Suicide in pregnancy.
-
The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
-
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
-
The use of pharmacotherapies for smoking cessation during pregnancy.
-
Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.
-
Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice.
-
Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program.
-
Use of bupropion in combination with serotonin reuptake inhibitors.
-
Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases.
-
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.
-
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
-
What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
-
Zyban: two products, two uses--too confusing?